PDB Short entry for 1QYY HEADER CELL ADHESION 12-SEP-03 1QYY TITLE CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PLATELET RECEPTOR TITLE 2 GLYCOPROTEIN IB-ALPHA AT 2.8 ANGSTROM RESOLUTION CAVEAT 1QYY MAN B 3 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLATELET GLYCOPROTEIN IB ALPHA CHAIN; COMPND 3 CHAIN: A, G; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN; COMPND 5 SYNONYM: GLYCOPROTEIN IBALPHA, GP-IB ALPHA, GPIBA, GPIB-ALPHA, CD42B- COMPND 6 ALPHA, CD42B; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GP1BA; SOURCE 6 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: S2 KEYWDS PLATELET RECEPTORS, GLYCOCALICIN, LEUCINE RICH REPEATS, CELL ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR K.I.VARUGHESE,Z.M.RUGGERI,R.CELIKEL REVDAT 6 27-OCT-21 1QYY 1 SEQADV HETSYN REVDAT 5 29-JUL-20 1QYY 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 13-JUL-11 1QYY 1 VERSN REVDAT 3 13-OCT-10 1QYY 1 REMARK REVDAT 2 24-FEB-09 1QYY 1 VERSN REVDAT 1 02-MAR-04 1QYY 0 JRNL AUTH K.I.VARUGHESE,Z.M.RUGGERI,R.CELIKEL JRNL TITL PLATINUM-INDUCED SPACE-GROUP TRANSFORMATION IN CRYSTALS OF JRNL TITL 2 THE PLATELET GLYCOPROTEIN IB ALPHA N-TERMINAL DOMAIN. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 60 405 2004 JRNL REFN ISSN 0907-4449 JRNL PMID 14993663 JRNL DOI 10.1107/S0907444903026805 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 15294 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : R FREE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 741 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4154 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 67 REMARK 3 SOLVENT ATOMS : 56 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1QYY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-OCT-03. REMARK 100 THE DEPOSITION ID IS D_1000020239. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-MAY-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL1-5 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.071564, 1.0079675 REMARK 200 MONOCHROMATOR : 2-CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16932 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.31700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: AB INITIO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, SODIUM NITRATE, SODIUM REMARK 280 ACETATE, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 56.91000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CHAIN A OR CHAIN G REPRESENT THE BIOLOGICAL UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 267 REMARK 465 GLY A 268 REMARK 465 ASP A 269 REMARK 465 GLU A 270 REMARK 465 GLY A 271 REMARK 465 ASP A 272 REMARK 465 THR A 273 REMARK 465 ASP A 274 REMARK 465 LEU A 275 REMARK 465 TYR A 276 REMARK 465 ASP A 277 REMARK 465 TYR A 278 REMARK 465 TYR A 279 REMARK 465 PRO A 280 REMARK 465 GLU A 281 REMARK 465 GLU A 282 REMARK 465 ASP A 283 REMARK 465 THR A 284 REMARK 465 GLU A 285 REMARK 465 GLY A 286 REMARK 465 ASP A 287 REMARK 465 LYS A 288 REMARK 465 VAL A 289 REMARK 465 ARG A 290 REMARK 465 LEU G 267 REMARK 465 GLY G 268 REMARK 465 ASP G 269 REMARK 465 GLU G 270 REMARK 465 GLY G 271 REMARK 465 ASP G 272 REMARK 465 THR G 273 REMARK 465 ASP G 274 REMARK 465 LEU G 275 REMARK 465 TYR G 276 REMARK 465 ASP G 277 REMARK 465 TYR G 278 REMARK 465 TYR G 279 REMARK 465 PRO G 280 REMARK 465 GLU G 281 REMARK 465 GLU G 282 REMARK 465 ASP G 283 REMARK 465 THR G 284 REMARK 465 GLU G 285 REMARK 465 GLY G 286 REMARK 465 ASP G 287 REMARK 465 LYS G 288 REMARK 465 VAL G 289 REMARK 465 ARG G 290 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O LEU G 196 O2 MAN B 4 1655 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 2 53.69 -108.81 REMARK 500 ILE A 3 -48.89 -131.74 REMARK 500 LYS A 8 -83.88 -144.04 REMARK 500 VAL A 9 111.10 35.19 REMARK 500 ALA A 10 101.95 27.01 REMARK 500 SER A 11 -98.14 48.19 REMARK 500 HIS A 12 106.27 -43.83 REMARK 500 LYS A 19 54.27 36.74 REMARK 500 ASN A 21 25.64 43.80 REMARK 500 ASP A 32 45.61 -84.33 REMARK 500 LEU A 42 73.99 -104.58 REMARK 500 LEU A 43 57.51 -100.90 REMARK 500 THR A 50 0.03 -59.20 REMARK 500 VAL A 72 75.99 -116.93 REMARK 500 ASP A 73 -89.07 -65.68 REMARK 500 THR A 98 -36.55 -145.07 REMARK 500 LEU A 99 63.36 -114.90 REMARK 500 PHE A 109 63.04 21.68 REMARK 500 ASN A 110 -159.66 -123.58 REMARK 500 ALA A 119 -54.16 -19.22 REMARK 500 ASN A 134 -158.67 -100.36 REMARK 500 PRO A 141 -76.49 -45.56 REMARK 500 THR A 147 75.56 -119.37 REMARK 500 ASN A 158 -140.69 -122.49 REMARK 500 ASN A 159 29.57 -140.41 REMARK 500 ASN A 182 -157.32 -121.60 REMARK 500 PRO A 206 39.88 -84.15 REMARK 500 TRP A 207 127.75 -30.85 REMARK 500 VAL A 234 127.49 -4.82 REMARK 500 ASP A 235 48.10 -108.44 REMARK 500 VAL A 236 0.90 54.93 REMARK 500 LYS A 237 44.79 29.09 REMARK 500 ALA A 238 71.59 -104.79 REMARK 500 MET A 239 137.68 155.64 REMARK 500 THR A 240 115.99 59.68 REMARK 500 ASN A 242 78.31 -167.24 REMARK 500 PRO G 2 107.64 -43.69 REMARK 500 ILE G 3 -32.53 -161.06 REMARK 500 VAL G 6 55.23 -142.68 REMARK 500 LYS G 8 -113.06 -65.10 REMARK 500 VAL G 9 149.03 76.86 REMARK 500 ALA G 10 68.50 25.56 REMARK 500 SER G 11 -41.40 56.12 REMARK 500 LEU G 13 117.70 -163.42 REMARK 500 ASP G 28 93.55 76.80 REMARK 500 PRO G 30 120.83 -32.18 REMARK 500 LEU G 42 65.84 -108.99 REMARK 500 TYR G 44 -25.69 -39.72 REMARK 500 THR G 50 9.37 -64.64 REMARK 500 TYR G 54 73.01 -106.26 REMARK 500 REMARK 500 THIS ENTRY HAS 74 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 PT A 506 PT REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 195 ND1 REMARK 620 2 HOH A 507 O 65.6 REMARK 620 N 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1P9A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PLATELET RECEPTOR REMARK 900 GLYCOPROTEIN IB-ALPHA AT 1.7 ANGSTROM RESOLUTION, TETRAGONAL P4(3) REMARK 900 FORM. REMARK 900 RELATED ID: 1OOK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX N-TERMINAL DOMAIN OF HUMAN REMARK 900 PLATELET RECEPTOR GLYCOPROTEIN IB-ALPHA AND HUMAN ALPHA-THROMBIN REMARK 900 RESOLUTION DBREF 1QYY A 1 290 UNP P07359 GPBA_HUMAN 17 306 DBREF 1QYY G 1 290 UNP P07359 GPBA_HUMAN 17 306 SEQADV 1QYY ALA A 65 UNP P07359 CYS 81 ENGINEERED MUTATION SEQADV 1QYY ALA G 65 UNP P07359 CYS 81 ENGINEERED MUTATION SEQRES 1 A 290 HIS PRO ILE CYS GLU VAL SER LYS VAL ALA SER HIS LEU SEQRES 2 A 290 GLU VAL ASN CYS ASP LYS ARG ASN LEU THR ALA LEU PRO SEQRES 3 A 290 PRO ASP LEU PRO LYS ASP THR THR ILE LEU HIS LEU SER SEQRES 4 A 290 GLU ASN LEU LEU TYR THR PHE SER LEU ALA THR LEU MET SEQRES 5 A 290 PRO TYR THR ARG LEU THR GLN LEU ASN LEU ASP ARG ALA SEQRES 6 A 290 GLU LEU THR LYS LEU GLN VAL ASP GLY THR LEU PRO VAL SEQRES 7 A 290 LEU GLY THR LEU ASP LEU SER HIS ASN GLN LEU GLN SER SEQRES 8 A 290 LEU PRO LEU LEU GLY GLN THR LEU PRO ALA LEU THR VAL SEQRES 9 A 290 LEU ASP VAL SER PHE ASN ARG LEU THR SER LEU PRO LEU SEQRES 10 A 290 GLY ALA LEU ARG GLY LEU GLY GLU LEU GLN GLU LEU TYR SEQRES 11 A 290 LEU LYS GLY ASN GLU LEU LYS THR LEU PRO PRO GLY LEU SEQRES 12 A 290 LEU THR PRO THR PRO LYS LEU GLU LYS LEU SER LEU ALA SEQRES 13 A 290 ASN ASN ASN LEU THR GLU LEU PRO ALA GLY LEU LEU ASN SEQRES 14 A 290 GLY LEU GLU ASN LEU ASP THR LEU LEU LEU GLN GLU ASN SEQRES 15 A 290 SER LEU TYR THR ILE PRO LYS GLY PHE PHE GLY SER HIS SEQRES 16 A 290 LEU LEU PRO PHE ALA PHE LEU HIS GLY ASN PRO TRP LEU SEQRES 17 A 290 CYS ASN CYS GLU ILE LEU TYR PHE ARG ARG TRP LEU GLN SEQRES 18 A 290 ASP ASN ALA GLU ASN VAL TYR VAL TRP LYS GLN GLY VAL SEQRES 19 A 290 ASP VAL LYS ALA MET THR SER ASN VAL ALA SER VAL GLN SEQRES 20 A 290 CYS ASP ASN SER ASP LYS PHE PRO VAL TYR LYS TYR PRO SEQRES 21 A 290 GLY LYS GLY CYS PRO THR LEU GLY ASP GLU GLY ASP THR SEQRES 22 A 290 ASP LEU TYR ASP TYR TYR PRO GLU GLU ASP THR GLU GLY SEQRES 23 A 290 ASP LYS VAL ARG SEQRES 1 G 290 HIS PRO ILE CYS GLU VAL SER LYS VAL ALA SER HIS LEU SEQRES 2 G 290 GLU VAL ASN CYS ASP LYS ARG ASN LEU THR ALA LEU PRO SEQRES 3 G 290 PRO ASP LEU PRO LYS ASP THR THR ILE LEU HIS LEU SER SEQRES 4 G 290 GLU ASN LEU LEU TYR THR PHE SER LEU ALA THR LEU MET SEQRES 5 G 290 PRO TYR THR ARG LEU THR GLN LEU ASN LEU ASP ARG ALA SEQRES 6 G 290 GLU LEU THR LYS LEU GLN VAL ASP GLY THR LEU PRO VAL SEQRES 7 G 290 LEU GLY THR LEU ASP LEU SER HIS ASN GLN LEU GLN SER SEQRES 8 G 290 LEU PRO LEU LEU GLY GLN THR LEU PRO ALA LEU THR VAL SEQRES 9 G 290 LEU ASP VAL SER PHE ASN ARG LEU THR SER LEU PRO LEU SEQRES 10 G 290 GLY ALA LEU ARG GLY LEU GLY GLU LEU GLN GLU LEU TYR SEQRES 11 G 290 LEU LYS GLY ASN GLU LEU LYS THR LEU PRO PRO GLY LEU SEQRES 12 G 290 LEU THR PRO THR PRO LYS LEU GLU LYS LEU SER LEU ALA SEQRES 13 G 290 ASN ASN ASN LEU THR GLU LEU PRO ALA GLY LEU LEU ASN SEQRES 14 G 290 GLY LEU GLU ASN LEU ASP THR LEU LEU LEU GLN GLU ASN SEQRES 15 G 290 SER LEU TYR THR ILE PRO LYS GLY PHE PHE GLY SER HIS SEQRES 16 G 290 LEU LEU PRO PHE ALA PHE LEU HIS GLY ASN PRO TRP LEU SEQRES 17 G 290 CYS ASN CYS GLU ILE LEU TYR PHE ARG ARG TRP LEU GLN SEQRES 18 G 290 ASP ASN ALA GLU ASN VAL TYR VAL TRP LYS GLN GLY VAL SEQRES 19 G 290 ASP VAL LYS ALA MET THR SER ASN VAL ALA SER VAL GLN SEQRES 20 G 290 CYS ASP ASN SER ASP LYS PHE PRO VAL TYR LYS TYR PRO SEQRES 21 G 290 GLY LYS GLY CYS PRO THR LEU GLY ASP GLU GLY ASP THR SEQRES 22 G 290 ASP LEU TYR ASP TYR TYR PRO GLU GLU ASP THR GLU GLY SEQRES 23 G 290 ASP LYS VAL ARG MODRES 1QYY ASN A 159 ASN GLYCOSYLATION SITE MODRES 1QYY ASN G 159 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET MAN B 3 11 HET MAN B 4 11 HET PT A 505 1 HET PT A 506 1 HET NAG G 601 14 HET PT G 602 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM PT PLATINUM (II) ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 3 NAG 3(C8 H15 N O6) FORMUL 3 MAN 2(C6 H12 O6) FORMUL 4 PT 3(PT 2+) FORMUL 8 HOH *56(H2 O) HELIX 1 1 ALA A 49 MET A 52 5 4 HELIX 2 2 ASN A 210 GLU A 212 5 3 HELIX 3 3 ILE A 213 ASN A 223 1 11 HELIX 4 4 ALA A 224 VAL A 227 5 4 HELIX 5 5 ASN A 242 VAL A 246 5 5 HELIX 6 6 GLN A 247 SER A 251 5 5 HELIX 7 7 PRO A 255 TYR A 259 5 5 HELIX 8 8 ALA G 49 MET G 52 5 4 HELIX 9 9 ASN G 210 GLU G 212 5 3 HELIX 10 10 ILE G 213 ASN G 223 1 11 HELIX 11 11 ALA G 224 VAL G 227 5 4 HELIX 12 12 ASN G 242 VAL G 246 5 5 HELIX 13 13 GLN G 247 SER G 251 5 5 HELIX 14 14 PRO G 255 TYR G 259 5 5 SHEET 1 A10 GLU A 5 VAL A 6 0 SHEET 2 A10 LEU A 13 ASN A 16 -1 O ASN A 16 N GLU A 5 SHEET 3 A10 THR A 33 HIS A 37 1 O ILE A 35 N VAL A 15 SHEET 4 A10 GLN A 59 ASN A 61 1 O GLN A 59 N LEU A 36 SHEET 5 A10 THR A 81 ASP A 83 1 O ASP A 83 N LEU A 60 SHEET 6 A10 VAL A 104 ASP A 106 1 O ASP A 106 N LEU A 82 SHEET 7 A10 GLU A 128 TYR A 130 1 O TYR A 130 N LEU A 105 SHEET 8 A10 LYS A 152 SER A 154 1 O SER A 154 N LEU A 129 SHEET 9 A10 THR A 176 LEU A 178 1 O LEU A 178 N LEU A 153 SHEET 10 A10 PHE A 199 PHE A 201 1 O PHE A 199 N LEU A 177 SHEET 1 B 2 THR A 45 SER A 47 0 SHEET 2 B 2 LYS A 69 GLN A 71 1 O GLN A 71 N PHE A 46 SHEET 1 C 9 GLU G 14 ASN G 16 0 SHEET 2 C 9 ILE G 35 HIS G 37 1 O ILE G 35 N VAL G 15 SHEET 3 C 9 GLN G 59 ASN G 61 1 O ASN G 61 N LEU G 36 SHEET 4 C 9 THR G 81 ASP G 83 1 O ASP G 83 N LEU G 60 SHEET 5 C 9 VAL G 104 ASP G 106 1 O ASP G 106 N LEU G 82 SHEET 6 C 9 GLU G 128 TYR G 130 1 O TYR G 130 N LEU G 105 SHEET 7 C 9 LYS G 152 SER G 154 1 O SER G 154 N LEU G 129 SHEET 8 C 9 THR G 176 LEU G 178 1 O LEU G 178 N LEU G 153 SHEET 9 C 9 PHE G 199 PHE G 201 1 O PHE G 199 N LEU G 177 SHEET 1 D 2 THR G 45 SER G 47 0 SHEET 2 D 2 LYS G 69 GLN G 71 1 O GLN G 71 N PHE G 46 SSBOND 1 CYS A 4 CYS A 17 1555 1555 2.03 SSBOND 2 CYS A 209 CYS A 248 1555 1555 2.02 SSBOND 3 CYS A 211 CYS A 264 1555 1555 2.03 SSBOND 4 CYS G 4 CYS G 17 1555 1555 2.03 SSBOND 5 CYS G 209 CYS G 248 1555 1555 2.02 SSBOND 6 CYS G 211 CYS G 264 1555 1555 2.03 LINK ND2 ASN A 159 C1 NAG B 1 1555 1555 1.45 LINK ND2 ASN G 159 C1 NAG G 601 1555 1555 1.46 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.40 LINK O4 NAG B 2 C1 MAN B 3 1555 1555 1.39 LINK O3 MAN B 3 C1 MAN B 4 1555 1555 1.39 LINK NE2 HIS A 86 PT PT A 505 1555 1555 2.31 LINK ND1 HIS A 195 PT PT A 506 1555 1555 2.48 LINK PT PT A 506 O HOH A 507 1555 1555 2.42 LINK NE2 HIS G 86 PT PT G 602 1555 1555 2.24 CRYST1 51.610 113.820 56.210 90.00 95.21 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019376 0.000000 0.001767 0.00000 SCALE2 0.000000 0.008786 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017864 0.00000